Diabetes and metabolic health news covering Type 1 and 2 diabetes, GLP-1 drugs, insulin access, and obesity science.
The Indian Express argues that frequent, short bursts of movement like stair climbing may offer superior blood sugar control compared to single gym sessions. Citing a diabetes educator, the article contends that frequency beats duration for glucose management, as daily activity interrupts prolonged sitting and reduces post-meal spikes.
Shelomi Sanders, daughter of Deion Sanders, shares her experience being diagnosed with Type 1 diabetes at age 13. She discusses her journey as a collegiate athlete and advocate, emphasizing the importance of mentorship and utilizing technology like Dexcom U to manage her condition while pursuing basketball.
The Indian Express article cites Dr. Himika Chawla to explain that insulin sensitivity improvements vary by individual factors like genetics and weight. It argues that while some gains occur within weeks, substantial metabolic changes require months of consistent lifestyle adjustments, specifically recommending 5-7% weight loss and 150 minutes of weekly exercise.
The authors argue that cardiovascular outcomes trials for GLP-1 receptor agonists have evolved from establishing safety to demonstrating significant clinical benefits. They highlight substantial reductions in major adverse cardiovascular events and kidney protection, noting recent evidence supporting oral semaglutide alongside traditional peptide analogues.
The Independent reports on research linking active brown fat deposits to reduced risks of type 2 diabetes, hypertension, and psychiatric conditions like depression. Based on a study of over 100,000 participants, the piece explains how brown fat burns white fat through specialized proteins, activated by cold or exercise, potentially offering new insights into metabolic and mental health disorders.
Bloomberg Intelligence argues that Tandem Diabetes is well-positioned to capitalize on the rapidly growing tubeless insulin pump market, citing annual growth rates exceeding 25%. The commentary highlights CEO John Sheridan’s confidence in the upcoming Mobi Tubless launch and AI-powered Control-IQ Plus algorithm as key drivers for future expansion.
The Indian Express reports that gastroenterologist Dr Pal Manickam argues diabetes poses a severe vascular risk comparable to smoking, causing arterial narrowing and clotting. He contends this creates a 'perfect storm' where poor blood flow and high sugar levels hinder infection treatment, significantly increasing the threat of limb-threatening complications.